“…At present, most reported cases of ONJ have been in oncology patients, with the vast majority of these cases being reported in cancer patients receiving high-dose intravenous (IV) bisphosphonate therapy in association with chemotherapy, radiotherapy, poor dental hygiene, or after a dental procedure. Published series of cases in more than 300 oncology patients have been extensively reviewed (1,2), with additional cases reported in patients with metastatic bone disease or multiple myeloma (3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)). In contrast, few cases of ONJ have been reported in patients receiving bisphosphonates for osteoporosis or osteopenia (1,2,13,18,(20)(21)(22), and the occurrence of ONJ in this population is thought to be very rare.…”